If it does prove to be the end of emraclidine for schizophrenia, that looks set to benefit Bristol-Myers Squibb, which ended ...

The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.

Investing.com - AbbVie (NYSE:ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia missed its primary endpoint, sending shares in the drugmaker down sharply in ...

Antipsychotic drug trials that specifically address the anti-hallucinatory effectiveness of the respective drugs in representative samples are rare. The aims of the present study were to ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

The use of antidementia and antipsychotic drugs for treating nursing home residents with dementia varies considerably across the United States, suggesting the need for better guidelines for ...

The US Food and Drug Administration (FDA) is poised to regulate a "potential first-in-class antipsychotic", known as KarXT, said Medscape. About one in 300 people worldwide are affected by ...

"Based on the evidence considered, no clear recommendation can be made for a specific antipsychotic medication," co-author Lena Feber, MSc, also of the Technical University of Munich School of ...

More information: Lena Feber et al, Antipsychotic Drugs and Cognitive Function, JAMA Psychiatry (2024). DOI: 10.1001/jamapsychiatry.2024.2890 ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Acadia Pharmaceuticals Inc. has persuaded a federal judge to trim claims from investment funds that said the drugmaker misled them into thinking an antipsychotic drug was poised for expanded use , ...